Member Info for Mikemine

To get a better picture of what the RNS means for LLAI, read the Sharecast piece in the Share News section. It looks like the pathway is now clear for launching the product and getting revenue. Long way to go as always but getting closer.

That's quite a step forward.

Did anybody manage to get to Bathgate today?

Thanks for your efforts BBN. We are looking at a potential future production need of 1000MWs per year and that is why I brought in the Siemens' aspect whereby they could use their huge engineering capability and know-how to do the heavy lifting. Motherwell's capacity will not be enough. I'm disappointed by the slippage of the Mistral launch but understand the reasoning behind it. I expect Gamesa has been insisting on a thorough testing and stressing before launch as Siemens has has had product failures recently and Gamesa would not want to add to that, risking Siemens pulling the rug on the project and Gamesa itself.

All through the presentation the message was of a growing market, acceptance of VFBs and engagement with big players eager to enter the long term non-lithium arena. IES is the front runner and is right in the middle of the mix. Its still risky of course but, boy, the potential that we've always known about could be unlocked very shortly. That is clear.

Is the clue in "Batteries"?

Could be and should be. If IES can sell one Mistral system to an AI company, I reckon lots will follow. The AIs will certainly need their own source of energy because it looks like the Grids here and the US will not cope in any way.

Thats not quite right. Last year they were talking about the end of Q1 or in to Q2 in 2024. Missing milestones seems to be in their DNA. I hope they get it right but they have been miles behind their promises over the years. Let's hope that improves this year. It certainly needs to be.

I don't think anybody would disagree that the demand for storage is growing and is going to be huge. It's quite big now. The questions for IES is will Mistral work, can they produce them in quantity and will they be bought? The turning point for me will be when Mistral is launched and the announcement of a large order for it. That will be a big, big derisk for me. It must happen in the next quarter surely.

Looks like some shorters are covering their positions. Could be that they've judged that the SP is likely to rise.

The US healthcare system has enormous coverage by insurance companies and it is often these that have to foot the bill for dialysis etc and that is a fortune. The insurance companies would be very positive about testing to keep their costs down by early intervention and of course the latest RNS indicates that the rest of the healthcare sector will be wide open to RENX's sales pitch. The CEO is a salesman by inclination and I'm not surprised that he has decided the company can go it alone and keep all the growth for itself and it's shareholders. I would not be surprised if the next financials reflect this.

I don't know the size of the Mistral units or indeed if they are units at all in the usual sense but the existing units are bigger than the equivalent lithium capacity batteries. But the can be much closer and stacked (no fire risk). For most grid applications size is not a big issue. In urban areas the noise from lithium cooling units might be a problem. I think VFBs are almost silent. In most applications I'm sure it will be a capex per KWH and the longevity that will be the main considerations. Mistral cost are 40% less than existing VFBs we are told and they hope to get that down to 60%. Hope that helps.

This might be behind a paywall but the article is about another small pharma quitting AIM, calling the whole UK Market broken with funds wanting to invest only in profitable companies.

Https://www.telegraph.co.uk/business/2024/04/10/london-markets-broken-closed-pharma-boss/

I don't think the petition has been going long sahid.

If the petition spreads over the boards, I'm sure the number will rise. Get spreading. Cut and paste if you want.

There is a petition going around to make shorting illegal in the UK. It won't make your broker or the shorter very happy as they've made tidy amounts over the years. In case anybody is unaware of the shorting process it goes like this. The shorter borrows your shares from the broker, bank etc who is looking after your shares for you. He pays a fee for this. He then sells your shares, usually in significant amounts, in the hope of buying them back at a lower price some time in the future. If there is enough shorting then there is a downward pressure on the SP and the price drops. Often on the stock market, as you know, investors will follow a trend, either up or down, so more selling comes in. At some point the shorter might buy back your shares at a good profit and return them to your broker. You will be unaware that your shares have been used this way but you will be aware of the drop in the value of them.

Shorter's and brokers say that the practice improves liquidity and sorts out the weak companies but that is just spin on what is essentially an immoral practice. Smaller companies like IES need continuous funding until they reach profitability. Attacking them by shorting means that they have to dilute shareholdings more because the SP has been lowered deliberately. So not only has your share holding lost value it is hit with double whammy by having excess dilution. How this practice can be allowed is beyond me and it's about time it was stopped.

Https://petition.parliament.uk/petitions/657294/signatures/new

Could NatPower be a strategic partner? They are certainly in a hurry so won't want planning to be held up with lithium fire issues and Mistral would fit in with the Government's eagerness to promote home grown businesses. Time will tell.

Someone mentioned VRCI, coming from the same stable, as being a takeover target but there is a difference. VRCI are now well funded and have just done a big deal. This puts them in a stronger position IMHO and any TO price would have to be at a hefty premium. There does seem to be increasing action in the diagnostic market though so who knows?

I've rarely seen a company with so much genuine potential. They've issued RNS after RNS about expanding the reach and availability of their product. The field they are in, however, is notoriously conservative and the take-up has been inevitably slow. When it does come, and it will, their position will be strong and profitable. Patience will be rewarded, IMHO, but it is hard to take right now.

Looks like most of the day traders have departed and the SP has stabilised around this level which is well up on the previous level a couple of weeks ago. If they can get the test more generally used this SP level will be a thing of the past.

The latest RNS was the latest in a very long line of positive RNSs largely ignored or misunderstood by the Market. The company has been viciously shorted for a long time and they must have made a fortune in the process. The SP response has a lot to do with day trading,IMHO, but also the realisation that the latest news opens the way for the American GPs to be encouraged by the Health authorities to be proactive and use the test routinely. That's big buck which will be funded by the Government.

A Lot depends on a lot as they say. Q1 2024 is covered but during that period they will be looking at cash flow predictions. They will have a better estimate of their position and may well have taken deposits for one or two Mistral orders that have been flagged. That might give them the confidence to go for debt to finance the rest of the year instead of share dilution. Where partnerships etc. fit in to all this I have no idea. It looks like it is all coming to a head next year and the bottom line, IMHO, is that dilution may be much less, if at all, than some fear. We can only sit back and see what unfolds next year as I doubt we will get any other news this year. In the meantime I'll wish everybody here a merry Christmas and prosperous New Year